Johnson & Johnson to spin off orthopedics unit named DePuy Synthes
NEW BRUNSWICK: Johnson & Johnson said Tuesday it plans to separate its orthopedics business into a standalone company named DePuy Synthes within the next 18 to 24 months, marking its second major spinoff in two years. The move comes as the health-care conglomerate raised its 2025 product revenue forecast to a range of $93.5 billion…